Last reviewed · How we verify

NCT03004430: MAMED

Mantra Meditation in Major Depression

Terminated NA Last updated 3 February 2021
What this trial tests

NA trial testing Mantra Meditation in Depression in 123 participants. Terminated before completion.

Timeline
12 January 2017
Primary endpoint
30 July 2020
30 July 2020

Quick facts

Lead sponsorDiakonie Kliniken Zschadraß
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment123
Start date12 January 2017
Primary completion30 July 2020
Estimated completion30 July 2020
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Diakonie Kliniken Zschadraß

Who can join

18 and older, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate effects of mantra meditation on depressive symptoms if applied as adjunctive therapy to psychotherapy and/or antidepressant drugs and to explore if meditation leads to increased spirituality as a potential mediating factor of positive mental health.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Mantra Meditation

Trials testing the same drug.

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Diakonie Kliniken Zschadraß trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03004430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing